Clinical Trials in Sousse, Tunisia
10 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Hoffmann-La Roche230 enrolled192 locationsNCT05894239
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
CRUZ Tunisia-Multivessel Registry
Patient Population With Multivessel Disease
Sahajanand Medical Technologies Limited1,000 enrolled2 locationsNCT06663696
Recruiting
Phase 2
Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression
Myopia
Laboratoires Thea200 enrolled10 locationsNCT07522242
Recruiting
Phase 3
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome
Primary Sjogrens Disease
argenx580 enrolled304 locationsNCT06684847
Recruiting
External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Upper Gastrointestinal Bleeding (UGIB)Glasgow-Blatchford Score
Hôpital Universitaire Sahloul250 enrolled1 locationNCT07089277
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
VEXAS SyndromeCastleman DiseaseUveitis+8 more
University of Siena3,500 enrolled112 locationsNCT05200715
Recruiting
Not Applicable
VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
Heart Failure
Population Health Research Institute891 enrolled9 locationsNCT05724433
Recruiting
Phase 3
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
Traumatic Injury
Riadh Boukef300 enrolled1 locationNCT06404177
Recruiting
Effects of Oncological Treatment During Pregnancy on Mother and Child
CancerPregnancy
University Hospital, Gasthuisberg5,000 enrolled33 locationsNCT00330447